• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cardium Therapeutics Inc

+ Add to Watchlist

42CN:GR

0.358 EUR 0.005 1.38%

As of 07:02:58 ET on 08/22/2014.

Snapshot for Cardium Therapeutics Inc (42CN)

Open: 0.358 Day's Range: 0.358 - 0.358 Volume: 0
Previous Close: 0.363 52wk Range: 0.333 - 0.818 1-Yr Rtn: -40.03%

Stock Chart for 42CN

No chart data available.
  • 42CN:GR 0.358
  • 1D
  • 1M
  • 1Y
0.363
Interactive 42CN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 42CN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 4.41
Shares Outstanding (M) 12.31
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/19/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 42CN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 42CN

Cardium Therapeutics Inc. is an interventional cardiology company. The Company focuses on late-stage clinical development and commercialization of DNA-based growth factor therapeutics as treatments for coronary artery disease and heart attack.

Christopher J ReinhardChairman/Pres/CEO/TreasurerDennis M MulroyChief Financial Officer
Gabor M RubanyiChief Scientific OfficerTyler M Dylan-HydeExec VP/Chief Bus Ofcr/Secy
More Company Profile & Key Executives for 42CN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil